Attached files

file filename
8-K - 8-K - IMAX CORPd616767d8k.htm

IMAX CORPORATION

Exhibit 99.1

 

LOGO

IMAX CORPORATION

2525 Speakman Drive

Mississauga, Ontario, Canada L5K 1B1

Tel: (905) 403-6500 Fax: (905) 403-6450

www.imax.com

IMAX CORPORATION REPORTS THIRD QUARTER 2013 FINANCIAL RESULTS

HIGHLIGHTS

 

  IMAX signs contracts for 99 theatres in the third quarter, bringing year-to-date signings to 158

 

  IMAX expands backlog to historical high of 356 theatres, a 25% increase year-over-year

 

  Third quarter box office of $133 million brings year-to-date box office to $482 million, a 3% increase year-over-year

NEW YORK, NY – Oct. 24, 2013 – IMAX Corporation (NYSE:IMAX; TSX:IMX) today reported third quarter 2013 revenues of $51.7 million, adjusted EBITDA as calculated in accordance with the Company’s credit facility of $14.8 million, adjusted net income of $4.4 million, or $0.06 per diluted share, and reported net income of $1.6 million, or $0.02 per diluted share.

“We continued to make significant progress this quarter toward our key strategic initiatives, including strong signings, controlling SG&A and continued advancements on differentiation,” stated Richard L. Gelfond, IMAX Chief Executive Officer. “Looking ahead, our great start to Q4, including IMAX’s strong performance on Gravity and Stalingrad, reminds us of the importance of assessing our portfolio of films on an annual basis, which we believe is a relatively predictable driver of box office performance over the long-term.”

Network Growth Update

The total IMAX® theatre network consisted of 785 systems as of September 30, 2013, of which 653 were in commercial multiplexes. There were 356 theatre systems in backlog as of September 30, 2013, compared to 285 theatre systems in backlog as of September 30, 2012. IMAX has signed contracts for 158 theatres year-to-date, already surpassing the 142 signings for all of 2012. Neither the backlog number, nor the YTD signings, include the 80 additional theatres still optional under the Wanda contract. For a breakdown of theatre system signings, installations, network and backlog by type, please see the end of this press release.

In the third quarter of 2013, the Company signed contracts for 99 theatre systems, of which 88 were in new theatre locations and 11 were a combination of signings for laser systems and upgrades of certain of the Company’s film theatres to digital systems in existing theatre locations. In the quarter, the Company installed 28 theatre systems, of which 19 were in new theatre locations.

“Strong third quarter signings, historic high backlog and many fourth quarter deals either signed or in discussions, provide increased visibility into strong network growth over the long-term,” Gelfond continued, “This unit growth, along with our ongoing focus on controlling costs and optimizing our film portfolio, give us confidence in our operating leverage and cash flow potential for the long-term.”

 

1


Third-Quarter Segment Results

 

    Revenue from sales and sales-type leases was $6.4 million in the third quarter of 2013, compared to $21.9 million in the third quarter of 2012, primarily reflecting the installation of 5 full, new theatre systems under sales and sales-type lease arrangements in the most recent third quarter, compared to the 14 sales and sales-type theatres the Company installed in the third quarter of 2012. The Company also installed 1 operating lease in a new location. In addition there were 9 digital system upgrades in existing locations in the third quarter of 2013, compared to 5 upgrades in the third quarter of 2012.

 

    Revenue from joint revenue-sharing arrangements was $12.0 million in the quarter, compared to $13.2 million in the prior-year period. During the quarter, the Company installed 13 new theatres under joint revenue-sharing arrangements, compared to 14 in the year-ago period. The Company had 351 theatres operating under joint revenue-sharing arrangements as of September 30, 2013, as compared to 287 theatres one year prior.

 

    Production and IMAX DMR® (Digital Re-Mastering) revenues were $14.5 million in the third quarter of 2013, compared to $25.2 million in the third quarter of 2012. Gross box office from DMR titles was $132.5 million in the third quarter of 2013, compared to $173.2 million in the prior-year period. The average global DMR box office per screen in the third quarter of 2013 was $207,500 compared to $312,000 in the prior-year period.

Conference Call

The Company will host a conference call today at 8:30 AM ET to discuss its third quarter 2013 financial results. To access the call via telephone, interested parties should dial (800) 711-9538 approximately 5 to 10 minutes before it begins. International callers should dial (416) 640-5925. The participant passcode for the call is 1695965. This call is also being webcast by Thomson Financial and can be accessed on the ‘Investor Relations’ section of www.imax.com. A replay of the call will be available via webcast on the ‘Investor Relations’ section of www.imax.com or via telephone by dialing (888) 203-1112 (US and Canada) or (647) 436-0148 (international). The Conference ID for the telephone replay is 1695965.

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you’ve never imagined. Top filmmakers and studios are utilizing IMAX theatres to connect with audiences in extraordinary ways, and, as such, IMAX’s network is among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto and Los Angeles, with offices in London, Tokyo, Shanghai and Beijing. As of September 30, 2013, there were 785 IMAX theatres (653 commercial multiplexes, 19 commercial destinations and 113 institutions) in 55 countries.

IMAX®, IMAX® 3D, IMAX DMR®, Experience It In IMAX®, An IMAX 3D Experience®, The IMAX Experience®, IMAX Is Believing® and IMAX nXos® are trademarks of IMAX Corporation. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).

###

This press release contains forward looking statements that are based on IMAX management’s assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, general economic, market or business conditions; the opportunities (or lack thereof) that may be presented to and pursued by the Company; the performance of IMAX DMR films; competitive actions by other companies; conditions in the in-home and out-of-home entertainment industries; the signing of theater system agreements; changes in laws or regulations; conditions, changes and developments in the commercial exhibition industry; the failure to convert theater system backlog into revenue; risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company’s growth and operations in China; the failure to respond to change and advancements in digital technology; risks related to the acquisition of AMC Entertainment Holdings, Inc. by Dalian Wanda Group Co., Ltd.; risks related to new business initiatives; the potential impact of increased competition in the markets within

 

2


which the Company operates; risks related to the Company’s inability to protect the Company’s intellectual property; risks related to Eastman Kodak bankruptcy and the possibility of constrained film supply; risks related to the Company’s implementation of a new enterprise resource planning system; risks related to the Company’s prior restatements and the related litigation; and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

For additional information please contact:

 

Investors:

IMAX Corporation, New York

Teri Loxam

212-821-0100

tloxam@imax.com

  

Media:

IMAX Corporation, New York

Ann Sommerlath

212-821-0155

asommerlath@imax.com

  

Business Media:

Sloane & Company, New York

Whit Clay

212-446-1864

wclay@sloanepr.com

  

Entertainment Media:

Principal Communications Group, Los Angeles

Melissa Zuckerman/Paul Pflug

323-658-1555

melissa@pcommgroup.com

paul@pcommgroup.com

  

 

3


Additional Information

Signings and Installations

 

Sep. 30, 2013

 

     Three Months
Ended Sep. 30,
 
     2013     2012  

Theatre Signings:

    

Full new sales and sales-type lease arrangements

     6        4   

New joint revenue sharing arrangements

     82        28   
  

 

 

   

 

 

 

Total new theatres

     88        32   

Upgrades of IMAX theatre systems

     11 (1)      9 (2) 
  

 

 

   

 

 

 

Total Theatre Signings

     99        41   
  

 

 

   

 

 

 
     Three Months
Ended Sep. 30,
 
     2013     2012  

Theatre Installations:

    

Full new sales and sales-type lease arrangements

     6 (3)      14   

New joint revenue sharing arrangements

     13        14   
  

 

 

   

 

 

 

Total new theatres

     19        28   

Upgrades of IMAX theatre systems

     9 (1)      5   
  

 

 

   

 

 

 

Total Theatre Installations

     28        33   
  

 

 

   

 

 

 
     As of Sep. 30,  
     2013     2012  

Theatre Backlog:

    

New sales and sales-type lease arrangements

     142        133   

New joint revenue sharing arrangements

     191        149   
  

 

 

   

 

 

 

Total new theatres

     333        282   

Upgrades of IMAX theatre systems

     23        3   
  

 

 

   

 

 

 

Total Theatres in Backlog

     356 (4)      285 (5) 
  

 

 

   

 

 

 
     As of Sep. 30,  
     2013     2012  

Theatre Network:

    

Commercial Multiplex Theatres:

    

Sales and sales-type lease arrangements

     302        269   

Joint revenue sharing arrangements

     351        287   
  

 

 

   

 

 

 

Total Commercial Multiplex Theatres

     653        556   

Commercial Destination Theatres

     19        20   

Institutional Theatres

     113        113   
  

 

 

   

 

 

 

Total IMAX Theatre Network

     785        689   
  

 

 

   

 

 

 

 

(1) Includes upgrades to xenon-based digital systems under short-term operating lease arrangements (4 signings, 3 installations).
(2) Includes 3 IMAX theaters acquired from another existing customer that has been operating under a joint revenue sharing arrangement. These theaters were purchased from the Company under a sales arrangement.
(3) Includes one full xenon-based digital system under a short-term operating lease arrangement.
(4) Includes 23 upgrades to a digital theater system, in an existing IMAX theater location (5 xenon, 18 laser of which 3 are under joint revenue sharing arrangements).
(5) Includes 3 upgrades to a digital theater system, in an existing IMAX theater location (2 xenon, 1 laser).

 

4


Additional Information (continued)

2013 DMR Films Announced to Date:

To date, IMAX has announced 37 titles to be released in 2013. The Company released 35 titles in 2012. The Company remains in discussions with virtually every major studio regarding future titles and expects the total number of titles in 2013 to be similar to that in 2012.

 

    The Grandmaster: The IMAX Experience (Jet Tone Films and Sil-Metropole Organization, January 2013, China only);

 

    Hansel & Gretel: Witch Hunters: An IMAX 3D Experience (Paramount Pictures, January 2013);

 

    Journey to the West: Conquering the Demons: An IMAX 3D Experience (Bingo Movie Development Ltd, February 2013, China only);

 

    Top Gun: An IMAX 3D Experience (Paramount Pictures, February 2013);

 

    A Good Day to Die Hard: The IMAX Experience (Twentieth Century Fox, February 2013);

 

    Jack the Giant Slayer: An IMAX 3D Experience (Warner Bros., March 2013);

 

    Oz: The Great and Powerful: An IMAX 3D Experience (Walt Disney Pictures, March 2013);

 

    G.I. Joe: Retaliation: An IMAX 3D Experience (Paramount Pictures, March 2013);

 

    Dragon Ball Z: Battle of the Gods: An IMAX 3D Experience (Toei Animation Company, March 2013, Japan only);

 

    Jurassic Park: An IMAX 3D Experience (Universal Pictures, April 2013);

 

    Oblivion: The IMAX Experience (Universal Pictures, April 2013);

 

    Iron Man 3: An IMAX 3D Experience (Walt Disney Pictures, May 2013);

 

    Star Trek: Into Darkness: An IMAX 3D Experience (Paramount Pictures, May 2013);

 

    Fast & Furious 6: The IMAX Experience (Universal, May 2013, international only);

 

    After Earth: The IMAX Experience (Sony, May 2013);

 

    Man of Steel: The IMAX Experience (Warner Bros., June 2013);

 

    World War Z: An IMAX 3D Experience (Paramount Pictures, June 2013, international only);

 

    Despicable Me 2: An IMAX 3D Experience (Universal Pictures, July 2013, international only);

 

    White House Down: The IMAX Experience (Colombia Pictures and Sony Pictures, July 2013; international only);

 

    Man of Tai Chi: The IMAX Experience (China Film Group, Wanda Group and Village Roadshow Pictures, July 2013; China only);

 

    Pacific Rim: An IMAX 3D Experience (Warner Bros., July 2013);

 

    The Lone Ranger : The IMAX Experience (Walt Disney Pictures, August 2013; international only);

 

    Elysium: The IMAX Experience (Sony, August 2013);

 

    Riddick Sequel: The IMAX Experience (Universal Pictures, September 2013);

 

    Mortal Instruments: City of Bones: The IMAX Experience (Sony, August 2013; domestic only);

 

    The Wizard of Oz: An IMAX 3D Experience (Warner Bros., September 2013; domestic only);

 

    Metallica Through the Never: An IMAX 3D Experience (Picturehouse, September 2013);

 

    Young Detective Dee: The IMAX Experience (Huayi Brothers, September 2013; China only);

 

    Stalingrad: An IMAX 3D Experience (AR Films, October 2013; Russia and the CIS only );

 

    Gravity: An IMAX 3D Experience (Warner Bros., October 2013);

 

    Captain Phillips: The IMAX Experience (Colombia Pictures and Sony Pictures, October 2013);

 

    The Young and Prodigious: T.S. Spivet: An IMAX 3D Experience (Gaumont, October 2013; France only);

 

    Ender’s Game: The IMAX Experience (Lionsgate, November 2013);

 

    Thor: The Dark World: An IMAX 3D Experience (Walt Disney Pictures, November 2013; international only);

 

    The Hunger Games: Catching Fire: The IMAX Experience (Lionsgate, November 2013);

 

    The Hobbit: The Desolation of Smaug: An IMAX 3D Experience (Warner Bros., December 2013); and

 

    Dhoom 3: The IMAX Experience (Yash Raj Films, 2013, India only).

 

5


IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars, except per share amounts)

(Unaudited)

 

     Three Months
Ended September 30,
    Nine Months
Ended September 30,
 
     2013     2012*     2013     2012*  

Revenues

        

Equipment and product sales

   $ 9,623     $ 24,327     $ 40,649     $ 55,756  

Services

     29,061       40,316       98,019       102,312  

Rentals

     10,987       14,013       38,782       42,912  

Finance income

     2,071       2,055       6,079       5,537  

Other

     —         —         375       —    
  

 

 

   

 

 

   

 

 

   

 

 

 
     51,742       80,711       183,904       206,517  
  

 

 

   

 

 

   

 

 

   

 

 

 

Costs and expenses applicable to revenues

        

Equipment and product sales

     4,086       10,652       20,561       27,727  

Services

     16,339       21,107       54,783       55,378  

Rentals

     4,059       4,202       11,687       12,968  

Other

     —         —         —         —    
  

 

 

   

 

 

   

 

 

   

 

 

 
     24,484       35,961       87,031       96,073  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

     27,258       44,750       96,873       110,444  

Selling, general and administrative expenses (including share-based compensation expense of $2.8 million and $8.8 million for the three and nine months ended September 30, 2013, respectively (2012 - expense of $2.8 million and $10.3 million, respectively))

     19,778       19,432       59,364       59,032  

Research and development

     3,974       2,528       11,267       7,623  

Amortization of intangibles

     409       166       1,146       532  

Receivable provision, net of recoveries

     224       241       279       829  

Impairment of available-for-sale investment

     —         —         —         150  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations

     2,873       22,383       24,817       42,278  

Interest income

     14       22       39       73  

Interest expense

     (315     (373     (1,008     (1,375
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations before income taxes

     2,572       22,032       23,848       40,976  

Provision for income taxes

     (619     (6,787     (6,564     (11,484

Loss from equity-accounted investments

     (344     (334     (998     (1,038
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 1,609     $ 14,911     $ 16,286     $ 28,454  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share - basic & diluted:

        

Net income per share - basic

   $ 0.02     $ 0.23     $ 0.24     $ 0.43  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share - diluted

   $ 0.02     $ 0.22     $ 0.24     $ 0.42  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of shares outstanding (000’s):

        

Basic

     67,309       65,930       66,969       65,718  

Fully Diluted

     69,116       68,301       68,853       68,187  

Additional Disclosure:

        

Depreciation and amortization(1)

   $ 8,826     $ 8,038     $ 29,027     $ 24,704  

 

(1) Includes $0.1 million and $0.3 million of amortization of deferred financing costs charged to interest expense for the three and nine months ended September 30, 2013, respectively (2012 — less than $0.1 million and $0.1 million, respectively).
* Reflects a revision resulting from an adjustment to reflect an unfunded postretirement obligation of the Company.

 

6


IMAX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

In accordance with United States Generally Accepted Accounting Principles

(in thousands of U.S. dollars)

 

     As at
September 31,
2013
    As at
December 31,
2012
 
     (unaudited)        

Assets

    

Cash and cash equivalents

   $ 25,955     $ 21,336  

Accounts receivable, net of allowance for doubtful accounts of $1,513 (December 31, 2012 - $1,564)

     44,321       42,007  

Financing receivables

     99,591       94,193  

Inventories

     14,306       15,794  

Prepaid expenses

     4,576       3,833  

Film assets

     6,305       3,737  

Property, plant and equipment

     126,930       113,610  

Other assets

     27,739       23,963  

Deferred income taxes

     31,052       36,461  

Goodwill

     39,027       39,027  

Other intangible assets

     27,688       27,911  
  

 

 

   

 

 

 

Total assets

   $ 447,490     $ 421,872  
  

 

 

   

 

 

 

Liabilities

    

Bank indebtedness

   $ 5,000     $ 11,000  

Accounts payable

     17,051       15,144  

Accrued and other liabilities

     67,181       68,695  

Deferred revenue

     73,789       73,954  
  

 

 

   

 

 

 

Total liabilities

     163,021       168,793  
  

 

 

   

 

 

 

Shareholders’ equity

    

Capital stock, common shares - no par value. Authorized - unlimited number.

    

Issued and outstanding - 67,518,740 (December 31, 2012 - 66,482,425)

     323,744       313,744  

Other equity

     33,642       28,892  

Deficit

     (70,880     (87,166

Accumulated other comprehensive loss

     (2,037     (2,391
  

 

 

   

 

 

 

Total shareholders’ equity

     284,469       253,079  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 447,490     $ 421,872  
  

 

 

   

 

 

 

 

7


IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars)

(Unaudited)

 

     Nine Months
Ended September 30,
 
     2013     2012*  

Cash provided by (used in):

    

Operating Activities

    

Net income

   $ 16,286     $ 28,454  

Adjustments to reconcile net income to cash from operations:

    

Depreciation and amortization

     29,027       24,704  

Write-downs, net of recoveries

     279       1,516  

Change in deferred income taxes

     5,579       9,431  

Stock and other non-cash compensation

     9,348       11,099  

Gain on curtailment of postretirement benefits

     (2,185     —    

Unrealized foreign currency exchange loss (gain)

     275       (152

Loss from equity-accounted investments

     998       1,038  

Investment in film assets

     (16,772     (13,508

Changes in other non-cash operating assets and liabilities

     (9,860     (8,672
  

 

 

   

 

 

 

Net cash provided by operating activities

     32,975       53,910  
  

 

 

   

 

 

 

Investing Activities

    

Purchase of property, plant and equipment

     (6,167     (2,599

Investment in joint revenue sharing equipment

     (16,363     (15,174

Investment in new business ventures

     (2,500     (381

Acquisition of other intangible assets

     (1,812     (5,046
  

 

 

   

 

 

 

Net cash used in investing activities

     (26,842     (23,200
  

 

 

   

 

 

 

Financing Activities

    

Increase in bank indebtedness

     12,000       9,917  

Repayment of bank indebtedness

     (18,000     (35,000

Common shares issued - stock options exercised

     6,745       5,831  

Credit facility amendment fees paid

     (2,089     —    

Share issuance expenses

     (202     —    
  

 

 

   

 

 

 

Net cash used in financing activities

     (1,546     (19,252
  

 

 

   

 

 

 

Effects of exchange rate changes on cash

     32       (146
  

 

 

   

 

 

 

Increase in cash and cash equivalents during the period

     4,619       11,312  

Cash and cash equivalents, beginning of period

     21,336       18,138  
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 25,955     $ 29,450  
  

 

 

   

 

 

 

 

8


IMAX CORPORATION

SELECTED FINANCIAL DATA

In accordance with United States Generally Accepted Accounting Principles

(in thousands of U.S. dollars)

The Company has seven reportable segments identified by category of product sold or service provided: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production; and other. The IMAX systems segment is comprised of the design, manufacture, sale or lease IMAX theater projection system equipment. The theater system maintenance segment consists of the maintenance of IMAX theater projection system equipment in the IMAX theater network. The joint revenue sharing arrangements segment is comprised of the installation IMAX theater projection system equipment to an exhibitor in exchange for a certain percentage of box-office receipts, concession revenue and in some cases a small upfront or initial payment. The film production and IMAX DMR segment is comprised of the production of films and performance of film re-mastering services. The film distribution segment includes the distribution of films for which the Company has distribution rights. The film post-production segment includes the provision of film post-production and film print services. The other segment includes certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items.

 

     Three Months
Ended September 30,
     Nine Months
Ended September 30,
 
     2013     2012      2013     2012  

Revenue

         

IMAX Theater Systems

         

IMAX Systems

         

Sales and sales-type leases

   $ 6,419     $ 21,937      $ 33,321     $ 49,751  

Ongoing rent, fees, and finance income

     3,483       3,421        10,111       9,312  

Other

     2,230       4,997        8,362       10,394  
  

 

 

   

 

 

    

 

 

   

 

 

 
     12,132       30,355        51,794       69,457  
  

 

 

   

 

 

    

 

 

   

 

 

 

Theater system maintenance

     8,103       7,042        23,844       20,878  
  

 

 

   

 

 

    

 

 

   

 

 

 

Joint revenue sharing arrangements

     11,960       13,186        39,672       40,477  
  

 

 

   

 

 

    

 

 

   

 

 

 

Film

         

Production and IMAX DMR

     14,547       25,223        54,854       58,805  

Film distribution and post-production

     5,000       4,905        13,740       16,900  
  

 

 

   

 

 

    

 

 

   

 

 

 
     19,547       30,128        68,594       75,705  
  

 

 

   

 

 

    

 

 

   

 

 

 

Total

   $ 51,742     $ 80,711      $ 183,904     $ 206,517  
  

 

 

   

 

 

    

 

 

   

 

 

 

Gross margins

         

IMAX Theater Systems

         

IMAX systems(1)

         

Sales and sales-type leases

   $ 3,928     $ 12,575      $ 16,390     $ 25,259  

Ongoing rent, fees, and finance income

     3,277       3,381        9,758       9,216  

Other

     (302     564        (29     287  
  

 

 

   

 

 

    

 

 

   

 

 

 
     6,903       16,520        26,119       34,762  
  

 

 

   

 

 

    

 

 

   

 

 

 

Theater system maintenance

     3,218       2,828        9,432       8,122  
  

 

 

   

 

 

    

 

 

   

 

 

 

Joint revenue sharing arrangements(1)

     7,153       9,286        26,796       28,340  
  

 

 

   

 

 

    

 

 

   

 

 

 

Film

         

Production and IMAX DMR(1)

     8,596       15,426        30,372       35,714  

Film distribution and post-production

     1,388       690        4,154       3,506  
  

 

 

   

 

 

    

 

 

   

 

 

 
     9,984       16,116        34,526       39,220  
  

 

 

   

 

 

    

 

 

   

 

 

 

Total

   $ 27,258     $ 44,750      $ 96,873     $ 110,444  
  

 

 

   

 

 

    

 

 

   

 

 

 

 

(1) IMAX systems include commission costs of $0.2 million and $0.9 million for the three and nine months ended September 30, 2013, respectively (2012 — $0.9 million and $2.1 million, respectively). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $0.9 million and $2.0 million for the three and nine months ended September 30, 2013, respectively (2012 — $1.1 million and $2.1 million, respectively). Production and IMAX DMR segment margins include marketing costs of $0.8 million and $3.1 million for the three and nine months ended September 30, 2013, respectively (2012 — $0.5 million and $2.2 million, respectively). Distribution segment margins include a marketing cost of $0.1 million and $0.2 million for the three and nine months ended September 30, 2013, respectively (2012 — recovery of less than $0.1 million and an expense of $1.2 million, respectively).

 

9


IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)

Non-GAAP Financial Measures:

In this release, the Company presents adjusted EBITDA, adjusted net income and adjusted net income per diluted share as supplemental measures of performance of the Company, which are not recognized under United States generally accepted accounting principles (“GAAP”). The Company presents adjusted EBITDA, adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its variable share-based compensation, provision for arbitration award and deferred taxes on its net income. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted EBITDA, adjusted net income and adjusted net income per diluted share should be considered in addition to, and not as a substitute for, net income and other measures of financial performance reported in accordance with GAAP.

Adjusted EBITDA is calculated on a basis consistent with the Company’s Credit Facility, which refers to Adjusted EBITDA as EBITDA. The Credit Facility provides that the Company will be required to maintain a Fixed Charge Coverage Ratio (as defined in the Credit Agreement) of not less than 1.1:1. The Company will also be required to maintain minimum EBITDA (as defined in the Credit Agreement) of $70.0 million between closing and September 30, 2013, which requirement increases to $80.0 million on December 31, 2013, $90.0 million on December 31, 2014, and $100.0 million on December 31, 2015. The Company must also maintain a Maximum Total Leverage Ratio (as defined in the Credit Agreement) of 2.5:1 between closing and September 30, 2013, which requirement decreases to (i) 2.25:1 on December 31, 2013; (ii) 2.00:1 on December 31, 2014; and (iii) 1.75:1 on December 31, 2015. The ratio of total debt to EBITDA was 0.06:1 as at September 30, 2013, where Total Debt (as defined in the Credit Agreement) is the sum of all obligations evidenced by notes, bonds, debentures or similar instruments and was $5.0 million. EBITDA is calculated as follows:

 

     3 months ended
September 30, 2013
     12 months ended
September 30, 2013(1)
 
(In thousands of U.S Dollars)              

Net income

   $ 1,609      $ 29,169  

Add:

     

Loss from equity accounted investments

     344        1,322  

Provision for income taxes

     619        10,159  

Interest expense, net of interest income

     301        271  

Depreciation and amortization, including film asset amortization

     8,699        36,716  

Write-downs net of recoveries including asset impairments and receivable provisions

     224        370  

Stock and other non-cash compensation

     3,031        12,469  

Gain on curtailment of postretirement benefits

     —          (2,185
  

 

 

    

 

 

 
   $ 14,827      $ 88,291  
  

 

 

    

 

 

 

 

(1) Ratio of funded debt calculated using twelve months ended EBITDA.

 

10


IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)

Adjusted Net Income and Adjusted Diluted Per Share Calculations – Quarter Ended September 30, 2013 vs. 2012:

The Company reported net income of $1.6 million or $0.02 per basic and diluted share for the third quarter of 2013, as compared to net income of $14.9 million or $0.23 per basic share and $0.22 per diluted share for the third quarter of 2012. The quarter ended September 30, 2012 included the exceptional performance of The Dark Knight Rises: The IMAX Experience. Net income for the third quarter of 2013 includes a $2.8 million charge, or $0.04 per diluted share, for stock-based compensation (2012 — $2.8 million or $0.04 per diluted share). Adjusted net income, which consists of net income excluding stock-based compensation expense and the related tax impact, was $4.4 million, or $0.06 per diluted share, in the third quarter of 2013, as compared to adjusted net income of $17.8 million, or $0.26 per diluted share, for the third quarter of 2012. A reconciliation of net income, the most directly comparable U.S. GAAP measure, to adjusted net income and adjusted net income per diluted share is presented in the table below:

 

     Three Months
Ended September 30, 2013
     Three Months
Ended September 30, 2012
 
     Net Income     Diluted EPS      Net Income      Diluted EPS  

Reported

   $ 1,609     $ 0.02      $ 14,911      $ 0.22  

Adjustments:

          

Stock-based compensation

     2,838       0.04        2,756        0.04  

Tax benefit on item listed above

     (85     —          114        —    
  

 

 

   

 

 

    

 

 

    

 

 

 

Adjusted

   $ 4,362     $ 0.06      $ 17,781      $ 0.26  
  

 

 

   

 

 

    

 

 

    

 

 

 

Weighted average diluted shares outstanding

       69,116           68,301  
    

 

 

       

 

 

 

Adjusted Net Income and Adjusted Diluted Per Share Calculations – Nine Months Ended September 30, 2013 vs. 2012:

The Company reported net income of $16.3 million or $0.24 per basic and diluted share for the nine months ended September 30, 2013, as compared to net income of $28.5 million or $0.43 per basic and $0.42 per diluted share for the nine months ended September 30, 2012. Net income for the nine months ended September 30, 2013 includes a $8.8 million charge, or $0.12 per diluted share, for stock-based compensation (2012 — $10.3 million or $0.15 per diluted share). Adjusted net income, which consists of net income excluding stock-based compensation expense and the related tax expense, was $24.9 million, or $0.36 per diluted share, in the nine months ended September 30, 2013, as compared to adjusted net income of $38.6 million, or $0.57 per diluted share, for the nine months ended September 30, 2012. A reconciliation of net income, the most directly comparable U.S. GAAP measure, to adjusted net income and adjusted net income per diluted share is presented in the table below:

 

     Nine Months
Ended September 30, 2013
     Nine Months
Ended September 30, 2012
 
     Net Income     Diluted EPS      Net Income     Diluted EPS  

Net income

   $ 16,286     $ 0.24      $ 28,454     $ 0.42  

Add:

         

Stock-based compensation

     8,772       0.12        10,252       0.15  

Tax expense on items listed above

     (159     —          (86     —    
  

 

 

   

 

 

    

 

 

   

 

 

 

Adjusted net income

   $ 24,899     $ 0.36      $ 38,620     $ 0.57  
  

 

 

   

 

 

    

 

 

   

 

 

 

Weighted average diluted shares outstanding

       68,853          68,187  
    

 

 

      

 

 

 

 

11


Free Cash Flow:

Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company’s after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. A reconciliation of cash provided by operating activities to free cash flow is presented in the table below:

 

(In thousands of U.S. Dollars)    Nine Months
Ended September 30, 2013
 

Net cash provided by operating activities

   $ 32,975  

Net cash (used in) investing activities

     (26,842
  

 

 

 

Free cash flow

   $ 6,133  
  

 

 

 

 

12